Psychedelic drug makers rally as Trump orders FDA to expedite reviews [Yahoo! Finance]
Trade Mark Registry Proceedings at the UKIPO Training Course (ONLINE EVENT: May 13, 2026) [Yahoo! Finance]
AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
AtaiBeckley: BPL-003 Phase 3 Momentum Keeps Me Bullish [Seeking Alpha]